Conference item
I131-MIBG treatment revisited: How important is scheduling when combined with external beam irradiation?
- Abstract:
- Neuroblastoma is the most frequent extra-cranial tumour in younger childhood. The current treatment of high-risk (stage 4) inoperable neuroblastoma includes a combination of chemotherapy and/or total irradiation with either autologous bone marrow transplantation or peripheral blood stem cell reinfusion. Despite these treatments the 4-year overall survival for high-stage neuroblastoma is still low (69%). Targeted/molecular radiotherapy (MRT) where the overexpressed noradrenaline transporter is targeted with 131I-MIBG (Meta-iodobenzylguanidine) an analogue of noradrenaline is an effective treatment for relapsed or refractory neuroblastoma. The aim of this study is to investigate whether in vivo imaging could be used to inform scheduling of MRT with 131I-MIBG in a human neuroblastoma xenograft model (SK-N-SH) to optimize and enhance the efficacy of external beam irradiation (EBRT).
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
- Publisher:
- Society of Nuclear Medicine
- Host title:
- Journal of Nuclear Medicine
- Journal:
- Journal of Nuclear Medicine More from this journal
- Volume:
- 57
- Issue:
- 6
- Pages:
- *e7677*
- Publication date:
- 2016-05-01
- EISSN:
-
1535-5667
- ISSN:
-
0161-5505
- Pubs id:
-
pubs:917681
- UUID:
-
uuid:6ae95925-9ab5-48bb-baa1-f4299e08e5d4
- Local pid:
-
pubs:917681
- Source identifiers:
-
917681
- Deposit date:
-
2018-10-30
Terms of use
- Copyright holder:
- Society of Nuclear Medicine and Molecular Imaging
- Copyright date:
- 2016
- Notes:
- Copyright © 2018 Society of Nuclear Medicine and Molecular Imaging. This is the accepted manuscript version of the abstract. The final version is available online from the Society of Nuclear Medicine at: http://jnm.snmjournals.org/content/57/supplement_2/470?related-urls=yes&legid=jnumed;57/supplement_2/470
If you are the owner of this record, you can report an update to it here: Report update to this record